A Risperdal lawyer is lobbying the FDA to publish documents that purportedly reveal undisclosed side effects caused by the controversial antipsychotic, but are currently classified under a court order. The documents were sealed by a Philadelphia judge as part of the ongoing litigation against drug... Read More

Consumer watchdog group Public Citizen warns of the dangers associated with off-label use of prescription medications among the elderly, including atypical antipsychotics like Risperdal. Their recent newsletter cites disturbing research that shows at least 20 percent of prescriptions doled out in nursing homes over the... Read More

Earlier this fall, Johnson & Johnson negotiated a Risperdal settlement for an undisclosed sum with 21-year old Aaron Banks. Banks, who began taking the antipsychotic at age nine, developed gynecomastia, or male breast tissue, and held J&J liable for his condition and subsequent psychological trauma.... Read More

In 2006, the FDA approved the use of Risperdal for treating irritability associated with autism in children and adolescents, and in 2007, for treating schizophrenia and bipolar disorder in the same group. Post-marketing reports associated with the medication, however, indicated that some patients were suffering... Read More